203503-03-1

Basic information

• Product Name: (3R,4R)-N1-BOC-4-amino-3-hydroxypiperidine
• Synonyms: (3R,4R)-N1-BOC-4-amino-3-hydroxypiperidine;1-Piperidinecarboxylic acid, 4-aMino-3-hydroxy-, 1,1-diMethylethyl ester;tert-butyl 4-AMino-3-hydroxy-1-piperidinecarboxylate;1,1-Dimethylethyl 4-amino-3-hydroxy-1-piperidinecarboxylate;tert-Butyl 4-amino-3-hydroxypiperidine-1-carboxylate;N1-BOC-4-aMino-3-hydroxypiperidine
• CAS NO: 203503-03-1
• Molecular Formula: C₁₀H₂₀N₂O₃
• Molecular Weight: 216.2774
• Mol File: 203503-03-1.mol

Chemical Properties

• Boiling Point: 326.1±42.0 °C(Predicted)
• Appearance: /
• Density: 1.142±0.06 g/cm3(Predicted)
• PKA: 14.37±0.40(Predicted)
• CAS DataBase Reference: (3R,4R)-N1-BOC-4-amino-3-hydroxypiperidine(CAS DataBase Reference)
• NIST Chemistry Reference: (3R,4R)-N1-BOC-4-amino-3-hydroxypiperidine(203503-03-1)
• EPA Substance Registry System: (3R,4R)-N1-BOC-4-amino-3-hydroxypiperidine(203503-03-1)

Safety Data

• Hazardous Substances Data: 203503-03-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(3R,4R)-N1-BOC-4-amino-3-hydroxypiperidine is used as a key building block for the synthesis of various pharmaceuticals and bioactive molecules. Its unique structure and the presence of a BOC-protected amino group make it a valuable intermediate in the development of new drugs with specific therapeutic properties.
Used in Organic Chemistry:
(3R,4R)-N1-BOC-4-amino-3-hydroxypiperidine is used as a versatile chemical intermediate in organic chemistry for the synthesis of complex organic compounds. The BOC group can be easily removed under mild acidic conditions, enabling further functionalization of the molecule for specific applications in organic synthesis.
Used in Drug Development:
(3R,4R)-N1-BOC-4-amino-3-hydroxypiperidine is used as a starting material in the development of new drugs and materials. Its wide-ranging potential in medicinal chemistry allows researchers to explore its use in the creation of innovative therapeutic agents with improved efficacy and selectivity.
Used in Bioactive Molecule Synthesis:
(3R,4R)-N1-BOC-4-amino-3-hydroxypiperidine is used as a crucial component in the synthesis of bioactive molecules with potential applications in various fields, such as pharmaceuticals, agrochemicals, and materials science. Its unique structure and functional groups contribute to the development of molecules with specific biological activities.

Upstream product

• 71233-25-5 ethyl 1-tert-butoxycarbonyl-3-oxopiperidine-4-carboxylate 
• 71233-28-8 3-hydroxypiperidine-1,4-dicarboxylic acid 1-tert-butyl ester 4-ethyl ester 
• 1427170-50-0 C₁₁H₂₀N₂O₄ 
• 85838-94-4 N-Boc-1,2,3,6-tetrahydropyridine 
• 161157-50-2 tert-butyl 7-oxa-3-azabicyclo[4.1.0]heptane-3-carboxylate 
• 203503-02-0 tert-butyl (3RS,4RS)-4-azido-3-hydroxy-piperidine-1-carboxylate 

Downstream Products

• 203503-04-2 (4R,S)-((S)-2-benzyloxycarbonylamino-4-methylpentanoylamino)-(3R,S)-hydroxypiperidine-1-carboxylic acid tert-butyl ester 
• 1565853-00-0 C₁₆H₃₀N₂O₃ 
• 1565846-67-4 C₁₈H₂₆BrN₃O₃ 
• 652170-11-1 4-[N-[1-[N-(benzofuran-2-ylcarbonyl)amino]cyclohexanecarbonyl]amino]-1-tert-butoxycarbonyl-3-piperidinol 
• 652171-10-3 4-[N-[1-[N-(furan-2-ylcarbonyl)amino]cyclohexanecarbonyl]amino]-1-tert-butoxycarbonyl-3-piperidinol 
• 203501-32-0 {(S)-1-[4-((S)-2-Benzyloxycarbonylamino-4-methyl-pentanoylamino)-3-hydroxy-piperidine-1-carbonyl]-3-methyl-butyl}-methyl-carbamic acid benzyl ester 
• 203501-38-6 [(S)-1-(1-Acetyl-3-hydroxy-piperidin-4-ylcarbamoyl)-3-methyl-butyl]-carbamic acid benzyl ester 
• 203501-30-8 ((S)-1-{1-[(4R,S)-((S)-2-benzyloxycarbonylamino-4-methylpentanoylamino)-(3R,S)-hydroxypiperidin-1-yl]methanoyl}-3-methylbutyl)carbamic acid benzyl ester 

Relevant articles and documents

TBK/IKK INHIBITOR COMPOUNDS AND USES THEREOF

The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TBK/IKKε inhibitors.

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

The present invention provides compounds of Formula (I) (Formula (I)) including pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.

Synthesis and in vitro antibacterial activity of quinolone/naphthyridone derivatives containing 3-alkoxyimino-4-(methyl)aminopiperidine scaffolds

We report herein the synthesis of a series of 7-[3-alkoxyimino-4-(methyl) aminopiperidin-1-yl]quinolone/naphthyridone derivatives. In vitro antibacterial activity of these derivatives was evaluated against representative strains, and compared with ciprofl

Dipeptidyl peptidase IV inhibitors derived from β-aminoacylpiperidines bearing a fused thiazole, oxazole, isoxazole, or pyrazole

A series of β-aminoacylpiperidines bearing various fused five-membered heterocyclic rings was synthesized as dipeptidyl peptidase IV inhibitors. Potent and relatively selective inhibition could be obtained, depending on choice of heterocycle, regioisomerism, and substitution. In particular, one analog (74, DPP-IV IC50 = 26 nM) exhibited good oral bioavailability and acceptable half-life in the rat, albeit with rather high clearance.

1-PHENYLPIPERIDIN-3-ONE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF

The present invention provides 1-phenylpiperidin-3-one derivatives and pharmaceutically acceptable saltsthereof, having cysteine protease inhibitory activity, pharmaceutical compositions containing the sameas an active ingredient, and processes for the preparation thereof.